Jing Jin

Title: Innovations of Jing Jin

Introduction

Jing Jin is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative peptides. His work focuses on enhancing energy metabolism and managing blood glucose levels.

Latest Patents

Jing Jin holds a patent for a glucagon-derived peptide and its applications. The patent describes a polypeptide derivative, modified derivative, or salt thereof, which exhibits a dual agonistic effect on GC/GLP-1 receptors. This innovative approach generates a synergistic effect on energy metabolism, effectively reducing blood glucose levels while also promoting weight loss and improving body fat levels. The efficacy of this invention surpasses that of a single GLP-1 receptor agonist.

Career Highlights

Jing Jin is affiliated with the Tianjin Institute of Pharmaceutical Research Co., Ltd. His work at this institution has been pivotal in advancing research in peptide-based therapies. He has demonstrated a commitment to improving health outcomes through innovative scientific solutions.

Collaborations

Jing Jin collaborates with several esteemed colleagues, including Yingmei Han and Wei Liu. Their combined expertise contributes to the success of their research initiatives and the development of groundbreaking therapies.

Conclusion

Jing Jin's contributions to the field of pharmaceutical research, particularly through his innovative peptide patent, highlight his role as a leading inventor in Tianjin, China. His work continues to pave the way for advancements in energy metabolism and diabetes management.